X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3130) 3130
Newsletter (195) 195
Book Chapter (170) 170
Magazine Article (21) 21
Reference (19) 19
Book / eBook (10) 10
Newspaper Article (10) 10
Publication (8) 8
Dissertation (7) 7
Web Resource (5) 5
Conference Proceeding (4) 4
Book Review (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
varicella-zoster virus (1982) 1982
science & technology (1747) 1747
humans (1735) 1735
life sciences & biomedicine (1704) 1704
varicella zoster virus (1198) 1198
female (825) 825
male (810) 810
chickenpox (693) 693
shingles (636) 636
virus diseases (619) 619
adult (597) 597
viruses (590) 590
herpes zoster (543) 543
middle aged (512) 512
health aspects (501) 501
immunology (427) 427
aged (419) 419
herpesvirus 3, human - immunology (418) 418
virology (396) 396
infectious diseases (371) 371
herpesvirus 3, human - genetics (362) 362
child (345) 345
varicella (340) 340
research (334) 334
herpesvirus 3, human - isolation & purification (333) 333
herpes simplex virus (330) 330
adolescent (313) 313
child, preschool (284) 284
vaccines (280) 280
chicken pox (276) 276
vaccination (268) 268
polymerase chain reaction (257) 257
antiviral agents - therapeutic use (254) 254
infections (238) 238
animals (237) 237
acyclovir (228) 228
integumentary system (224) 224
infant (219) 219
microbiology (218) 218
risk factors (218) 218
pediatrics (207) 207
herpes zoster - virology (205) 205
abridged index medicus (203) 203
analysis (201) 201
cytomegalovirus (195) 195
aged, 80 and over (185) 185
herpesvirus 3, human - physiology (183) 183
neurosciences & neurology (181) 181
herpes zoster - complications (172) 172
acyclovir - therapeutic use (169) 169
antibodies, viral - blood (167) 167
care and treatment (160) 160
diagnosis (155) 155
herpesvirus 3, human (152) 152
herpes zoster - immunology (149) 149
antiviral agents (139) 139
young adult (139) 139
dna, viral - analysis (138) 138
herpes zoster - drug therapy (138) 138
herpes zoster - diagnosis (137) 137
children (136) 136
neurosciences (136) 136
varicella‐zoster virus (136) 136
medical research (134) 134
prevention (134) 134
chickenpox - epidemiology (129) 129
chickenpox - prevention & control (129) 129
chickenpox - virology (127) 127
herpes zoster - epidemiology (127) 127
herpes zoster - prevention & control (126) 126
clinical neurology (124) 124
medicine & public health (124) 124
epidemiology (123) 123
herpesvirus 3, human - drug effects (123) 123
infection (122) 122
ophthalmology (122) 122
physiological aspects (118) 118
retrospective studies (115) 115
medicine, experimental (114) 114
medicine, research & experimental (112) 112
pregnancy (112) 112
chickenpox - immunology (111) 111
research & experimental medicine (111) 111
general & internal medicine (110) 110
herpesvirus 3, human - pathogenicity (109) 109
case report (107) 107
encephalitis (106) 106
epstein-barr virus (106) 106
pharmacology & pharmacy (104) 104
cell line (102) 102
medicine, general & internal (102) 102
herpes viruses (100) 100
immunocompromised host (100) 100
biochemical phenomena, metabolism, and nutrition (97) 97
incidence (97) 97
genetic aspects (96) 96
usage (96) 96
infant, newborn (94) 94
neurology (94) 94
immunization (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3304) 3304
Japanese (69) 69
French (63) 63
German (55) 55
Korean (43) 43
Spanish (34) 34
Czech (16) 16
Portuguese (16) 16
Russian (15) 15
Turkish (12) 12
Chinese (10) 10
Polish (8) 8
Dutch (4) 4
Italian (3) 3
Norwegian (3) 3
Hebrew (2) 2
Hungarian (2) 2
Persian (2) 2
Slovenian (2) 2
Catalan (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs & Aging, ISSN 1170-229X, 02/2010, Volume 27, Issue 2, pp. 159 - 176
Individuals who have been infected with varicella zoster virus (VZV) are at risk for developing herpes zoster and this risk appears to be related to a decline... 
Herpes-zoster, prevention | Adis-Drug-Evaluations | Varicella-zoster-virus-vaccine-live, pharmacodynam | Varicella-zoster-virus-vaccine-live, pharmacokinet | Postherpetic-neuralgia, prevention | Varicella-zoster-virus-vaccine-live, therapeutic u | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Varicella-zoster-virus-vaccine-live, pharmacokinetics | Herpes-zoster, Prevention | Varicella-zoster-virus-vaccine-live, pharmacodynamics | Varicella-zoster-virus- vaccine-live, therapeutic use | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Herpes Zoster - prevention & control | Age Factors | Humans | Vaccination | Cost of Illness | Herpesvirus 3, Human - immunology | Vaccines, Attenuated - economics | Incidence | Neuralgia, Postherpetic - prevention & control | Neuralgia, Postherpetic - immunology | Vaccines, Attenuated - administration & dosage | Neuralgia, Postherpetic - epidemiology | Adult | Herpes Zoster - epidemiology | Chickenpox Vaccine - economics | Cost-Benefit Analysis - economics | Herpes Zoster - immunology | Risk Factors | Immunocompetence - immunology | Treatment Outcome | Chickenpox Vaccine - administration & dosage | Health Services for the Aged | Herpes Zoster Vaccine - economics | Herpes Zoster Vaccine - administration & dosage | Randomized Controlled Trials as Topic | Immunity, Cellular - immunology | Antibodies, Viral - immunology | Immunologic Memory | Prevention | Complications and side effects | Shingles (Disease) | Herpesvirus vaccines | Aged | Dosage and administration | Research | Neuralgia | Health aspects | Risk factors | Index Medicus
Journal Article
Journal of neurovirology, ISSN 1538-2443, 12/2015, Volume 22, Issue 3, pp. 376 - 388
textabstractPrimary simian varicella virus (SVV) infection in non-human primates causes varicella, after which the virus becomes latent in ganglionic neurons... 
Sensory ganglia | Immune response | Varicella-zoster virus | Primary infection | Simian varicella virus | Neurology | Neurosciences | Biomedicine | Immunology | Infectious Diseases | Virology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antigens, CD - immunology | Virus Latency | Sensory Receptor Cells - immunology | Cercopithecus aethiops | Herpesvirus 3, Human - immunology | Ganglia, Sensory - virology | Granzymes - genetics | Primate Diseases - immunology | Varicella Zoster Virus Infection - immunology | Antigens, CD - genetics | CD11c Antigen - immunology | Ganglia, Sensory - immunology | CD11c Antigen - genetics | Primate Diseases - pathology | Chemokine CXCL10 - immunology | Granzymes - immunology | Primate Diseases - genetics | Virus Activation | Antigens, Differentiation, Myelomonocytic - immunology | Varicella Zoster Virus Infection - veterinary | Immediate-Early Proteins - immunology | Viral Envelope Proteins - genetics | Gene Expression Regulation - immunology | Varicella Zoster Virus Infection - genetics | Sensory Receptor Cells - virology | Viral Load - genetics | Viral Load - immunology | Antigens, Differentiation, Myelomonocytic - genetics | Host-Pathogen Interactions | DNA, Viral - immunology | Animals | Immediate-Early Proteins - genetics | CD8-Positive T-Lymphocytes - virology | Chemokine CXCL10 - genetics | Varicella Zoster Virus Infection - pathology | Herpesvirus 3, Human - pathogenicity | Immunologic Memory | Viral Envelope Proteins - immunology | CD8-Positive T-Lymphocytes - immunology | DNA, Viral - genetics | Index Medicus
Journal Article
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 12, pp. 2122 - 2125
Journal Article